Trials / Completed
CompletedNCT00380263
PACAP38´s (Pituitary Adenylate Cyclase-Activating Polypeptide) Headache Inducing Characteristics and Effects on the Cerebral Blood Flow
Basic Scientific Research Investigating PACAP38 Headache Inducing Effects in Migraine Patients
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 12 (actual)
- Sponsor
- Danish Headache Center · Academic / Other
- Sex
- All
- Age
- 18 Years – 50 Years
- Healthy volunteers
- Not accepted
Summary
To investigate headache score and accompanying symptoms during and after infusion of PACAP38 i migraine patients
Detailed description
To investigate headache score and accompanying symptoms during and after infusion of PACAP38 Changes in regional cerebral blood flow (rCBF) in the area supplied by middle cerebral artery (MCA), blood flow in MCA, diameter of the superficial temporal artery (STA) and radial artery (RA)
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | PACAP38 | 10 pmol/kg/min given one time |
Timeline
- Start date
- 2006-11-01
- Primary completion
- 2007-11-01
- Completion
- 2007-11-01
- First posted
- 2006-09-25
- Last updated
- 2008-05-30
Locations
1 site across 1 country: Denmark
Source: ClinicalTrials.gov record NCT00380263. Inclusion in this directory is not an endorsement.